Ampersand Capital Partners

Skip to content


Read what's happening in Ampersand's Portfolio.

December 1, 2014

Bioclinica Names Dr. John Hubbard Chief Executive Officer

October 29, 2014

Ampersand Exits Chantest Investment

July 14, 2014

ATS Labs, Inc. Announces the Acquisition of MicroTest Labs, Inc.

July 1, 2014

Ampersand Sells Viracor-IBT to Eurofins for $255 Million

June 10, 2014

Bioventus Announces U.S. Debut of Feature-Rich New EXOGEN® Device

April 30, 2014

NDC Launches New Brand Strategy

February 4, 2014

Bioventus Acquires DUROLANE Assets from Galderma

January 16, 2014

Merger to Create Leading Provider of Specialty Outsourced Clinical Services

January 1, 2014

Shaping the Next Generation of Cardiovascular Devices Through Biomedical Textile Engineering

Short-term Milestones & Long-term Growth